Chemotherapy Toxicity in Elderly Women with Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

What we are studying

This is an observational study, not a treatment study. The major goal of this study is to see if physicians can predict how women will tolerate and complete chemotherapy as prescribed, using simple assessments of their ability to do activities of daily living. Another goal of the study is to look at how chemotherapy works in older women with cancer, and for this reason you will be asked to allow some research blood to be drawn in order to measure the amount of chemotherapy drug(s) in your blood.

Who we are studying

  • Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 70 - 100

Eligibility Criteria

  • Diagnosis of any of the folloing:
    • Adenocarcinoma of Ovary
    • Adenocarcinoma of Peritoneum
    • Adenocarcinoma of Fallopian Tube
  • Not received treatment previously for Cancer

What is involved

  • 1 prescreen visit
  • 1 visit prior to each cycle of chemo
  • 1 visit after cycles 2 & 4
  • 1 visit after cycle 4
  • Blood draws and questionnaire only

Compensation

None

Contact Information

Study Coordinator
Melissa Swain
Email
mswain@wakehealth.edu
Phone
336-716-9428

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.